Abram Scientific's $11.75M Funding: Revolutionizing Coagulation Diagnostics with CoagCare™ Abram Scientific has closed an $11.75 million Series A funding round led by Octapharma AG to accelerate the development of its CoagCare™ diagnostic platform.

Abram Scientific's $11.75M Funding: Revolutionizing Coagulation Diagnostics with CoagCare™ #United_States #Menlo_Park #Octapharma #Abram_Scientific #CoagCare